212 related articles for article (PubMed ID: 18350832)
1. [Evaluation of the effect of anti-motion sickness pharmaceuticals on adaptation to the model conditions of long-term rotation].
Orlov OI
Aviakosm Ekolog Med; 2007; 41(6):24-8. PubMed ID: 18350832
[TBL] [Abstract][Full Text] [Related]
2. [Effect of adaptive biofeedback on the severity of vestibulo-autonomic symptoms of experimental motion sickness].
Smirnov SA; Aĭzikov GS; Kozlovskaia IB
Kosm Biol Aviakosm Med; 1988; 22(4):35-9. PubMed ID: 3265749
[TBL] [Abstract][Full Text] [Related]
3. Vestibular adaptation to centrifugation does not transfer across planes of head rotation.
Garrick-Bethell I; Jarchow T; Hecht H; Young LR
J Vestib Res; 2008; 18(1):25-37. PubMed ID: 18776596
[TBL] [Abstract][Full Text] [Related]
4. Prevention of overt motion sickness by incremental exposure to otherwise highly stressful coriolis accelerations.
Graybiel A; Deane FR; Colehour JK
Aerosp Med; 1969 Feb; 40(2):142-8. PubMed ID: 5304382
[No Abstract] [Full Text] [Related]
5. Effects of pre-exposures to a rotating optokinetic drum on adaptation to motion sickness.
Hu SQ; Stern RM; Koch KL
Aviat Space Environ Med; 1991 Jan; 62(1):53-6. PubMed ID: 1996932
[TBL] [Abstract][Full Text] [Related]
6. Rapid vestibular adaptation in a rotating environment by means of controlled head movements.
Graybiel A; Wood CD
Aerosp Med; 1969 Jun; 40(6):638-43. PubMed ID: 5305841
[No Abstract] [Full Text] [Related]
7. [Human tolerance to rotation at different levels of increased gravitation].
Genin AM; Kotovskaia AR; Galle RR; Gavrilova LN; Sarkisov IIu
Kosm Biol Aviakosm Med; 1982; 16(1):70-4. PubMed ID: 6977679
[TBL] [Abstract][Full Text] [Related]
8. [Motion sickness (author's transl)].
Fischer AJ; Oosterveld WJ
HNO; 1979 Sep; 27(9):285-91. PubMed ID: 396285
[TBL] [Abstract][Full Text] [Related]
9. Progressive adaptation to Coriolis accelerations associated with 1-rpm increments in the velocity of the slow rotation room.
Reason JT; Graybiel A
Aerosp Med; 1970 Jan; 41(1):73-9. PubMed ID: 5309794
[No Abstract] [Full Text] [Related]
10. Neurohumoral reactions to long-term vestibular stimulation in man.
Nichiporuk IA; Rapotkov AN; Orlov OI; Grigoriev AI
Physiologist; 1993 Feb; 36(1 Suppl):S5-8. PubMed ID: 11538529
[TBL] [Abstract][Full Text] [Related]
11. Prevention of motion sickness in flight maneuvers, aided by transfer of adaptation effects acquired in the laboratory: ten consecutive referrals.
Graybiel A; Knepton J
Aviat Space Environ Med; 1978 Jul; 49(7):914-9. PubMed ID: 666686
[TBL] [Abstract][Full Text] [Related]
12. The retention of adaptation to motion sickness eliciting stimulation.
Hu S; Stern RM
Aviat Space Environ Med; 1999 Aug; 70(8):766-8. PubMed ID: 10447049
[TBL] [Abstract][Full Text] [Related]
13. Desensitization to strong vestibular stimuli improves tolerance to simulated aircraft motion.
Cheung B; Hofer K
Aviat Space Environ Med; 2005 Dec; 76(12):1099-104. PubMed ID: 16370258
[TBL] [Abstract][Full Text] [Related]
14. Optokinetic drum tilt hastens the onset of vection-induced motion sickness.
Bubka A; Bonato F
Aviat Space Environ Med; 2003 Apr; 74(4):315-9. PubMed ID: 12688448
[TBL] [Abstract][Full Text] [Related]
15. Slow deep breathing prevents the development of tachygastria and symptoms of motion sickness.
Jokerst MD; Gatto M; Fazio R; Stern RM; Koch KL
Aviat Space Environ Med; 1999 Dec; 70(12):1189-92. PubMed ID: 10596772
[TBL] [Abstract][Full Text] [Related]
16. What you thought you knew about motion sickness isn't necessarily so.
Cowings PS; Malmstrom FV
Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877
[TBL] [Abstract][Full Text] [Related]
17. Prevention of overt motion sickness by incremental exposure to otherwise highly stressful Coriolis accelerations. NAMI-1044.
Graybiel A; Deane FR; Colehour JK
NASA Contract Rep NASA CR; 1968 May; ():1-13. PubMed ID: 5303710
[No Abstract] [Full Text] [Related]
18. Effects of vestibular training on motion sickness, nystagmus, and subjective vertical.
Clément G; Deguine O; Bourg M; Pavy-LeTraon A
J Vestib Res; 2007; 17(5-6):227-37. PubMed ID: 18626134
[TBL] [Abstract][Full Text] [Related]
19. [Neuroendocrine factors in pathogenesis of motion sickness and the protective effect of drugs].
Shashkov AV; Karsanova SK; Iasnetsov VV; Tigranian RA; Shashkov VS
Eksp Klin Farmakol; 2004; 67(2):3-7. PubMed ID: 15188750
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of the preparation Gavinton in preventing motion sickness].
Bodo D; Kotovskaia AR; Galle RR; Gavrilova LN; Gusakova GA
Kosm Biol Aviakosm Med; 1982; 16(3):49-51. PubMed ID: 7098411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
